Effects of Erythropoietin-Stimulating Agents on Blood Pressure in Patients with Non-Dialysis CKD and Renal Anemia

INTRODUCTION: Erythropoietin-stimulating agents (ESAs) are used to treat renal anemia in patients with non-dialysis CKD, but this can lead to increases in blood pressure (BP). OBJECTIVE: We investigated the effects of continuous erythropoietin receptor activator (CERA) and darbepoetin alfa (DA) on o...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Kidney Dis (Basel)
Autori principali: Ohki, Kohji, Wakui, Hiromichi, Uneda, Kazushi, Azushima, Kengo, Haruhara, Kotaro, Kinguchi, Sho, Urate, Shingo, Yamada, Takayuki, Yamaji, Takahiro, Kobayashi, Ryu, Kanaoka, Tomohiko, Minegishi, Shintaro, Ishigami, Tomoaki, Fujikawa, Tetsuya, Toya, Yoshiyuki, Tamura, Kouichi
Natura: Artigo
Lingua:Inglês
Pubblicazione: S. Karger AG 2020
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7445655/
https://ncbi.nlm.nih.gov/pubmed/32903814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000507396
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi